Bristol-Myers Squibb Company (BMY) Begins Tender Offer to Acquire KOSAN Biosciences, Inc. (KOSN)  
5/30/2008 10:46:52 AM

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) is commencing today, through its wholly owned subsidiary KB Acquisition Corp., a cash tender offer to purchase all outstanding shares of common stock of Kosan Biosciences Inc. (NASDAQ: KOSN). Bristol-Myers Squibb reported earlier today its intent to acquire Kosan.